go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

New Jersey rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $851,138 · 10th–90th $13,490$1,548,8170%20%10th90th$851,138Professionalmedian $562,341 · 10th–90th $512,861$707,9460%50%10th90th$562,341$200.0$1.0K$5.0K$20.0K$100.0K$500.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$724,435.96
Median
$851,138.04
Typical High
$1,905,460.72
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$758,577.58
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
Emblem Health
Setting
Professional
Modifier
Global
Typical Low
$478,630.09
Median
$562,341.33
Typical High
$912,010.84
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$1,737.80
Median
$14,791.08
Typical High
$1,380,384.26
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$512,861.38
Median
$512,861.38
Typical High
$537,031.80
United
Setting
Facility
Modifier
Global
Typical Low
$426,579.52
Median
$691,830.97
Typical High
$1,000,000.00
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$512,861.38
Typical High
$741,310.24